CA 15-3 is predictive of response and disease recurrence following treatment in locally advanced breast cancer
<p>Abstract</p> <p>Background</p> <p>Primary chemotherapy (PC) is used for down-staging locally advanced breast cancer (LABC). CA 15-3 measures the protein product of the MUC1 gene and is the most widely used serum marker in breast cancer.</p> <p>Methods<...
Main Authors: | McDermott Enda W, Myers Eddie, Kelly Gabrielle, Al-azawi Dhafir, Hill Arnold DK, Duffy Michael J, Higgins Niall O |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2006-09-01
|
Series: | BMC Cancer |
Online Access: | http://www.biomedcentral.com/1471-2407/6/220 |
Similar Items
-
The role of major duct excision and microdochectomy in the detection of breast carcinoma
by: Evoy Denis, et al.
Published: (2006-06-01) -
Incarcerated transmesosigmoid hernia presenting in a 60-year-old man: a case report
by: Collins Danielle, et al.
Published: (2008-05-01) -
Blood-based biomarkers in breast cancer: From proteins to circulating tumor cells to circulating tumor DNA
by: Michael J Duffy, et al.
Published: (2018-05-01) -
Electronic learning can facilitate student performance in undergraduate surgical education: a prospective observational study
by: Gorey Thomas, et al.
Published: (2005-06-01) -
Crystallisation of 2CaO:Pâ†2Oâ†5 glass ceramics with additions of TiOâ†2, Alâ†2Oâ†3,MgO, SiOâ†2,CaFâ†2 and ZrOâ†2
by: McDermott, Alistair James
Published: (1999)